Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors

OptiBiotix 'gaining real commercial traction' - CEO Stephen O'Hara

Stephen O'Hara, chief executive of OptiBiotix Health plc (LON:OPTI), tells Proactive they're to launch an improved version of their weight loss product Slimbiome at a major US trade fair at the end of the month.

Optibiotix already has US product registration for Slimbiome, which is a patented combination of natural ingredients, and will launch the new version at the Supply Side West trade show where it will be exhibited with Cereal Ingredients Inc, a potential joint development partner.

In a wide-ranging discussion O'Hara also brought Proactive up to speed on developments with LPLDL - another of their innovations that is gaining market traction.

OptiBiotix struck a profit-sharing deal with Italian firm Sacco to manufacture and supply the cholesterol-reducing compound and the first sales of the product were made to HLH BioPharma Vertriebs.

 
Meet Amur Minerals Corporation, Lekoil Ltd, SDX Energy Inc and Tethyan Resources PLC at our event, London, 19 October 2017. Register here »
View full OPTI profile View Profile

OptiBiotix Health plc Timeline

© Proactive Investors 2017

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use